🇺🇸 FDA
Patent

US 11213592

Antibody-sting agonist conjugates and their use in immunotherapy

granted A61KA61K47/6807A61K47/6849

Quick answer

US patent 11213592 (Antibody-sting agonist conjugates and their use in immunotherapy) held by The Board of Regents of the University of Texas System expires Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K47/6807, A61K47/6849, A61K47/6851, A61P